A subsequent new drug (SND) is a modified version of an approved drug, requiring regulatory approval for changes in strength, dosage form, route of administration, or indication. It undergoes evaluation for safety, efficacy, and quality based on additional clinical or non-clinical data as per regulatory guidelines. https://www.dueranconsultancy.com/drugs-licenses